Form 4: BioLife Solutions EVP Aby J. Mathew Sells Shares to Cover Tax Obligations

Aby J. Mathew, EVP & Chief Scientific Officer of BioLife Solutions Inc., sold 569 shares of common stock on April 9, 2025, to cover tax withholding obligations related to vesting restricted stock.

Summary

• On April 9, 2025, Aby J. Mathew, the EVP & Chief Scientific Officer of BioLife Solutions Inc. (BLFS), sold 569 shares of common stock.
• The sale was executed at a price of $20.11 per share.
• The transaction was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted on January 3, 2023.
• The purpose of the sale was to satisfy tax withholding obligations associated with the vesting of restricted stock.
• Following the transaction, Mathew directly owns 309,007 shares of BioLife Solutions Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transaction is a routine sale of shares to cover tax obligations, executed under a pre-existing trading plan. It doesn't necessarily indicate a positive or negative outlook on the company.

Industry Context

Insider sales, especially those executed under pre-arranged trading plans like Rule 10b5-1, are common and often related to personal financial planning rather than a negative outlook on the company. It's important to consider the context and the size of the transaction relative to the individual's total holdings.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but the pre-planned nature of the transaction mitigates potential concerns.

Key Dates

Keywords

BioLife Solutions, BLFS, Aby J. Mathew, Form 4, insider trading, stock sale, Rule 10b5-1, tax obligations, restricted stock, EVP & Chief Scientific Officer